Drug-induced Brugada Syndrome Research Database
Launched by UNIVERSITY OF CAMPANIA LUIGI VANVITELLI · Sep 8, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding a condition called drug-induced Brugada Syndrome, which can lead to serious heart rhythm problems. Researchers will gather information from patients who have this syndrome to learn more about their experiences and the treatments they receive. By studying these patients, the trial aims to identify important factors that could help predict health outcomes and improve future care for those affected by this condition.
If you or a loved one has been diagnosed with drug-induced Brugada Syndrome, you may be eligible to participate in this study. The trial is open to all patients who meet the criteria, as long as they provide informed consent and are willing to be contacted for follow-up. Participants can expect to be part of a registry where their health information will be carefully recorded and analyzed. This is an important step in advancing our understanding of this syndrome and may contribute to better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All consecutive patients with drug-induced Brugada Syndrome
- Exclusion Criteria:
- • Missing Informed Consent Form
- • Missing Contact Informations for Follow up
About University Of Campania Luigi Vanvitelli
The University of Campania Luigi Vanvitelli is a distinguished academic institution located in Italy, renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive expertise in biomedical sciences to conduct innovative studies that address critical health challenges. With a focus on ethical standards and patient safety, the university collaborates with various healthcare professionals and research entities to facilitate groundbreaking clinical investigations, ultimately contributing to the development of new therapies and enhancing medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Naples, Napoli, Italy
Patients applied
Trial Officials
Vincenzo Russo, MD PhD
Study Chair
University of Campania Luigi Vanvitelli
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials